EcoDrugPlus

Dopamine Receptor D2

Ensembl ID : ENSCMIG00000007480
Gene Symbol: DRD2
4 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSCMIG00000010022
Gene Symbol: DRD3
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSCMIG00000019173
Gene Symbol: DRD4
3 Cross references
245 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSCMIG00000016928
Gene Symbol: DRD5
3 Cross references
188 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSCMIG00000011162
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCMIG00000011688
Gene Symbol: EGLN1
4 Cross references
240 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSCMIG00000003240
Gene Symbol: EGLN3
4 Cross references
210 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSCMIG00000005662
Gene Symbol: EPAS1
4 Cross references
225 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSCMIG00000003805
Gene Symbol: ECE1
4 Cross references
262 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSCMIG00000008970
Gene Symbol: EDNRA
4 Cross references
270 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSCMIG00000011810
Gene Symbol: EDNRB
3 Cross references
267 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSCMIG00000007349
Gene Symbol: EZH2
4 Cross references
240 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).